Novo Nordisk
-
Business & Markets · Enterprise Novo Nordisk and Valo Health Expand AI-Driven Partnership to Tackle Chronic Diseases
Novo Nordisk and AI-focused Valo Health have announced an expanded collaboration to accelerate the discovery and development of treatments for obesity, type 2 diabetes, and cardiovascular disease. The partnership leverages Valo’s Opal Computational Platform™,… -
Technology & Infrastructure · Models & LLMs London Welcomes Novo Nordisk’s New AI Research Centre
-
Business & Markets · Enterprise Valo Health & Novo Nordisk to Collaborate to Discover & Develop Novel Treatments for Cardiometabolic Diseases Using Human Data & AI
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.